Status:
RECRUITING
The Prescription Patterns and Clinical Efficacy of Tenero Tab/Tenero M SR Tab
Lead Sponsor:
Hanlim Pharm. Co., Ltd.
Conditions:
Diabetes Mellitus, Type 2
Eligibility:
All Genders
19+ years
Brief Summary
This study is to observe the prescription patterns and clinical efficacy of patients prescribed with Tenero Tab/Tenero M SR Tab for diabetes treatment in routine clinical practice.
Detailed Description
This study is to observe the clinical efficacy by analyzing the prescription patterns in routine clinical practice and changes in HbA1c, FPG, PP2G, etc., of patients prescribed with Tenero Tab/Tenero ...
Eligibility Criteria
Inclusion
- Adults over 19 years of age
- Individuals diagnosed with type 2 diabetes.
- Individuals who, at the clinical discretion, are prescribed Tenero Tab or Tenero M SR Tab for the purpose of diabetes treatment for the first time.
- Individuals who have voluntarily provided written consent to participate in this study.
Exclusion
- Pregnant or breastfeeding women.
- Individuals who are contraindicated according to the approved indications of Tenero Tab/Tenero M SR Tab.
- Other cases where the principal investigator and study personnel deem individuals ineligible for participation in this clinical trial.
Key Trial Info
Start Date :
December 27 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2026
Estimated Enrollment :
3000 Patients enrolled
Trial Details
Trial ID
NCT06188234
Start Date
December 27 2022
End Date
June 1 2026
Last Update
February 15 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cheonan Endo Medical Clinic
Cheonan, South Korea